ICHR (NASDAQ: ICHR) files Form 144 to sell 19,875 restricted shares

Rhea-AI Filing Summary

ICHR notice of proposed sale of 19,875 restricted common shares filed on 02/23/2026.

The filing lists an aggregate offering price of $988,029.98 and reports 34,644,332 shares outstanding as of 02/23/2026. The securities listed are restricted stock grants by grant date and award amounts.

Insights

Equity Capital Markets Analyst

Form 144 notifies a proposed resale of restricted common shares totaling 19,875.

The filing shows a proposed sale amount of 19,875 shares with an aggregate offering price of $988,029.98 dated 02/23/2026. The securities listed are identified by grant dates and share counts.

Cash-flow treatment is not detailed beyond the aggregate price; timing and method of sale depend on holder actions and regulatory conditions.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	19875	988029.98	34644332	02/23/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/15/2018	Restricted Stock	Issuer			1266	08/15/2018	Not Applicable
Common	05/10/2024	Restricted Stock	Issuer			4752	05/10/2024	Not Applicable
Common	05/11/2020	Restricted Stock	Issuer			4432	05/11/2020	Not Applicable
Common	05/12/2023	Restricted Stock	Issuer			5635	05/12/2023	Not Applicable
Common	05/11/2022	Restricted Stock	Issuer			2526	05/11/2022	Not Applicable
Common	08/15/2020	Restricted Stock	Issuer			316	08/15/2020	Not Applicable
Common	08/15/2019	Restricted Stock	Issuer			316	08/15/2019	Not Applicable
Common	05/15/2020	Restricted Stock	Issuer			316	05/15/2020	Not Applicable
Common	11/15/2019	Restricted Stock	Issuer			316	11/15/2019	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the ICHR Form 144 disclose?

It discloses a proposed resale of 19,875 restricted common shares with an aggregate offering price of $988,029.98. The filing is dated 02/23/2026 and lists multiple grant dates and share counts for the restricted awards.

How many shares does the filing propose to sell for ICHR?

The filing proposes the resale of 19,875 common shares. The cover line pairs that share count with an aggregate offering price of $988,029.98, both shown on the filing dated 02/23/2026.

What aggregate value is listed on the ICHR Form 144?

The Form 144 shows an aggregate offering price of $988,029.98 associated with the proposed resale of the listed shares. That dollar figure appears on the same cover line dated 02/23/2026 in the excerpt provided.

Does the filing show shares outstanding for ICHR?

Yes; the filing shows 34,644,332 shares outstanding on the cover line dated 02/23/2026. This outstanding share count is presented alongside the proposed resale quantity and aggregate offering price in the excerpt.